The common lateral flow immunoassay format has become a truly quantified diagnostic test.
MIAstrip® offers rapid point of care testing in a single dose format capable
of identifying a wide analyte range. Objective, quantified and traceable
results are obtained via a portable reader in less than 20 minutes.
Direct electromagnetic reading provides actual quantification rather than
subjective visual interpretation or approximated colorimetric density
scanning. Unlike enzymatic detection labels, the MIAstrip® test persists,
thus providing the possibility to read the result at any time after the end of the assay. The quantified results are obtained directly and recorded electronically without human intervention. This unique
capability enables integrated downstream medical records management and
remote diagnostic capabilities via evolving telemedicine solutions.
MIAstrip® offers Next generation immunoassay® performance in a familiar and
proven format - a level of diagnostic performance previously available only
with laboratory methods.
Eased assay optimization and development
Beyond its dynamic capabilities, MIAtek™ can also accelerate assay development by establishing
very precise material balance across the reaction volume all the reaction long.In the development
of lateral-flow membrane tests for example, we can monitor sample and reagent migration
along the strip. This capability allows for precise test modelling and accelerates the speed of
new test development.
Optimization of assay conditions by the maximization of signal vs. background